My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 193

    1.

    Avastin in myopic choroidal neovascularisation: is age the limit?

    Wong D, Li KK.

    Br J Ophthalmol. 2008 Aug;92(8):1011-2. No abstract available. PMID: 18653589 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

    Rosenfeld PJ.

    Br J Ophthalmol. 2007 Feb;91(2):128-30. No abstract available. PMID: 17244654 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.

    Tewari A, Dhalla MS, Apte RS.

    Retina. 2006 Nov-Dec;26(9):1093-4. No abstract available. PMID: 17151505 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.

    Laud K, Spaide RF, Freund KB, Slakter J, Klancnik JM Jr.

    Retina. 2006 Oct;26(8):960-3. No abstract available. PMID: 17031300 [PubMed - indexed for MEDLINE]Related articles

    5.

    Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

    Nguyen QD, Shah S, Tatlipinar S, Do DV, Anden EV, Campochiaro PA.

    Br J Ophthalmol. 2005 Oct;89(10):1368-70. No abstract available. Erratum in: Br J Ophthalmol. 2006 Jan;90(1):125. PMID: 16170134 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.

    Arias L, Planas N, Prades S, Caminal JM, Rubio M, Pujol O, Roca G.

    Br J Ophthalmol. 2008 Aug;92(8):1035-9. Review.PMID: 18653595 [PubMed - indexed for MEDLINE]Related articles

    7.

    Papulopustular eruption after intravitreal bevacizumab (Avastin).

    Amselem L, Diaz-Llopis M, Garcia-Delpech S, Montero J, Palomares P, Cervera E.

    Acta Ophthalmol. 2009 Feb;87(1):110-1. Epub 2008 Jun 18. No abstract available. PMID: 18577190 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration.

    Chang LK, Spaide RF, Brue C, Freund KB, Klancnik JM Jr, Slakter JS.

    Arch Ophthalmol. 2008 Jul;126(7):941-5.PMID: 18625940 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Vitritis in the contralateral uninjected eye following intravitreal bevacizumab (Avastin).

    Neri P, Mariotti C, Mercanti L, Salvolini S, Giovannini A.

    Int Ophthalmol. 2008 Dec;28(6):425-7. Epub 2007 Oct 13.PMID: 17934693 [PubMed - indexed for MEDLINE]Related articles

    10.

    Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

    Ziemssen F, Heiduschka P, Schraermeyer U; Tübingen Bevacizumab Study Group.

    Retina. 2007 Oct;27(8):1154-6; author reply 1156-8. No abstract available. PMID: 18040264 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia.

    Rhéaume MA, Sebag M.

    Can J Ophthalmol. 2008 Oct;43(5):576-80.PMID: 18982035 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Avastin versus Lucentis: ethical issues in treatment of age-related macular degeneration.

    Klein RM, Klein RB.

    Retina. 2007 Nov-Dec;27(9):1163-5. No abstract available. PMID: 18046218 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Antiangiogenic therapy]

    Arias Barquet L.

    Arch Soc Esp Oftalmol. 2005 Aug;80(8):435-6. Spanish. No abstract available. PMID: 16136393 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Avastin and new treatments for AMD: where are we?

    Freeman WR, Falkenstein I.

    Retina. 2006 Oct;26(8):853-8. Review. No abstract available. PMID: 17031283 [PubMed - indexed for MEDLINE]Related articles

    15.

    Avastin versus Lucentis: ethical issues.

    Wong HC.

    Retina. 2008 Jul-Aug;28(7):1024-5; author reply 1025. No abstract available. PMID: 18698312 [PubMed - indexed for MEDLINE]Related articles

    16.

    Bevacizumab: a new way of doing business?

    Canning C, Lotery A.

    Eye (Lond). 2006 Sep;20(9):985-7. Epub 2006 Jul 21. Review.PMID: 16858443 [PubMed - indexed for MEDLINE]Related articles

    17.

    Shall we use Avastin or Lucentis for ocular neovascularization?

    Algvere PV, Kvanta A, Seregard S.

    Acta Ophthalmol. 2008 Jun;86(4):352-5. No abstract available. PMID: 18498548 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cheap shots and pricey propositions: evidence, disclosure, and treatment of age-related macular degeneration.

    Kimmelman J.

    Retina. 2007 Nov-Dec;27(9):1166-7. No abstract available. PMID: 18046219 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Bevacizumab (Avastin) in treatment of choroidal neovascularization secondary to age-related macular degeneration: a case report]

    Faria e Arantes TE, Nascimento VP, Maia OO Jr, Takahashi WY.

    Arq Bras Oftalmol. 2007 Nov-Dec;70(6):1016-20. Portuguese. PMID: 18235918 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Intravitreal VEGF-inhibitors: is Avastin a generic substitute for Lucentis?

    la Cour M.

    Acta Ophthalmol Scand. 2007 Feb;85(1):2-4. No abstract available. PMID: 17244202 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity